{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:22:35Z","timestamp":1783578155661,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41390-019-0580-8","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T13:02:39Z","timestamp":1568898159000},"page":"558-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity"],"prefix":"10.1038","volume":"87","author":[{"given":"Tammy Z.","family":"Movsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Paneth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira H.","family":"Gewolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Cavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arivalagan","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"key":"580_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara, N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581\u2013611 (2004).","journal-title":"Endocr. Rev."},{"key":"580_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/iovs.02-1096","volume":"45","author":"K Gogat","year":"2004","unstructured":"Gogat, K. et al. VEGF and KDR gene expression during human embryonic and fetal eye development. Invest. Ophthalmol. Vis. Sci. 45, 7\u201314 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"580_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/pr.2015.15","volume":"77","author":"IT Ma","year":"2015","unstructured":"Ma, I. T. et al. VEGF mRNA and protein concentrations in the developing human eye. Pediatr. Res. 77, 500\u2013505 (2015).","journal-title":"Pediatr. Res."},{"key":"580_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","volume":"62","author":"T Chan-Ling","year":"2018","unstructured":"Chan-Ling, T., Gole, G. A., Quinn, G. E., Adamson, S. J. & Darlow, B. A. Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog. Retin. Eye Res. 62, 77\u2013119 (2018).","journal-title":"Prog. Retin. Eye Res."},{"key":"580_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","volume":"122","author":"ME Hartnett","year":"2015","unstructured":"Hartnett, M. E. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 122, 200\u2013210 (2015).","journal-title":"Ophthalmology"},{"key":"580_CR6","first-page":"1162","volume":"368","author":"ME Hartnett","year":"2013","unstructured":"Hartnett, M. E. & Penn, J. S. Mechanisms and management of retinopathy of prematurity. N. Engl. J. Med. 368, 1162\u20131163 (2013).","journal-title":"N. Engl. J. Med."},{"key":"580_CR7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstrom","year":"2013","unstructured":"Hellstrom, A., Smith, L. E. & Dammann, O. Retinopathy of prematurity. Lancet 382, 1445\u20131457 (2013).","journal-title":"Lancet"},{"key":"580_CR8","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","volume":"15","author":"J Stone","year":"1995","unstructured":"Stone, J. et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738\u20134747 (1995).","journal-title":"J. Neurosci."},{"key":"580_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/dvdy.23743","volume":"241","author":"T Baba","year":"2012","unstructured":"Baba, T. et al. VEGF165b in the developing vasculatures of the fetal human eye. Dev. Dyn. 241, 595\u2013607 (2012).","journal-title":"Dev. Dyn."},{"key":"580_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1124\/jpet.106.104158","volume":"318","author":"MG Slomiany","year":"2006","unstructured":"Slomiany, M. G. & Rosenzweig, S. A. Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J. Pharm. Exp. Ther. 318, 666\u2013675 (2006).","journal-title":"J. Pharm. Exp. Ther."},{"key":"580_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-8-102","volume":"8","author":"LA Cole","year":"2010","unstructured":"Cole, L. A. Biological functions of hCG and hCG-related molecules. Reprod. Biol. Endocrinol. 8, 102 (2010).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"580_CR12","doi-asserted-by":"publisher","first-page":"E2037","DOI":"10.3390\/ijms18102037","volume":"18","author":"C Nwabuobi","year":"2017","unstructured":"Nwabuobi, C. et al. hCG: biological functions and clinical applications. Int. J. Mol. Sci. 18, E2037 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"580_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1095\/biolreprod.114.123711","volume":"92","author":"HA Trau","year":"2015","unstructured":"Trau, H. A., Davis, J. S. & Duffy, D. M. Angiogenesis in the primate ovulatory follicle is stimulated by luteinizing hormone via prostaglandin E2. Biol. Reprod. 92, 15 (2015).","journal-title":"Biol. Reprod."},{"key":"580_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jri.2009.11.008","volume":"85","author":"M Tsampalas","year":"2010","unstructured":"Tsampalas, M. et al. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J. Reprod. Immunol. 85, 93\u201398 (2010).","journal-title":"J. Reprod. Immunol."},{"key":"580_CR15","doi-asserted-by":"publisher","first-page":"e52567","DOI":"10.1371\/journal.pone.0052567","volume":"7","author":"S Dukic-Stefanovic","year":"2012","unstructured":"Dukic-Stefanovic, S. et al. Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions. PLoS ONE 7, e52567 (2012).","journal-title":"PLoS ONE"},{"key":"580_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2018.05.049","volume":"385","author":"TZ Movsas","year":"2018","unstructured":"Movsas, T. Z. et al. Confirmation of luteinizing hormone (LH) in living human vitreous and the effect of LH receptor reduction on murine electroretinogram. Neuroscience 385, 1\u201310 (2018).","journal-title":"Neuroscience"},{"key":"580_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02713683.2017.1377258","volume":"43","author":"TZ Movsas","year":"2018","unstructured":"Movsas, T. Z., Sigler, R. & Muthusamy, A. Elimination of signaling by the luteinizing hormone receptor reduces ocular VEGF and retinal vascularization during mouse eye development. Curr. Eye Res. 43, 1\u20134 (2018).","journal-title":"Curr. Eye Res."},{"key":"580_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/02713683.2018.1467932","volume":"43","author":"TZ Movsas","year":"2018","unstructured":"Movsas, T. Z., Sigler, R. & Muthusamy, A. Vitreous levels of luteinizing hormone and VEGF are strongly correlated in healthy mammalian eyes. Curr. Eye Res. 43, 1041\u20131044 (2018).","journal-title":"Curr. Eye Res."},{"key":"580_CR19","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1097\/WNR.0000000000001140","volume":"29","author":"TZ Movsas","year":"2018","unstructured":"Movsas, T. Z. & Muthusamy, A. The potential effect of human chorionic gonadotropin on vasoproliferative disorders of the immature retina. Neuroreport 29, 1525\u20131529 (2018).","journal-title":"Neuroreport"},{"key":"580_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1210\/jcem-46-6-994","volume":"46","author":"IT Huhtaniemi","year":"1978","unstructured":"Huhtaniemi, I. T., Korenbrot, C. C. & Jaffe, R. B. Content of chorionic gonadotropin in human fetal tissues. J. Clin. Endocrinol. Metab. 46, 994\u2013997 (1978).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"580_CR21","unstructured":"Melmed, S., Polonsky, K., S., Reed Larsen, P. & Kroneberg, H. Williams Textbook of Endocrinology 12th edn (Elsevier, Philadelphia, PA, 2011)."},{"key":"580_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1472-6483(10)61899-8","volume":"1","author":"E Jauniaux","year":"2000","unstructured":"Jauniaux, E., Pahal, G., Gervy, C. & Gulbis, B. Blood biochemistry and endocrinology in the human fetus between 11 and 17 weeks of gestation. Reprod. Biomed. Online 1, 38\u201344 (2000).","journal-title":"Reprod. Biomed. Online"},{"key":"580_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/pd.4578","volume":"35","author":"JL Browne","year":"2015","unstructured":"Browne, J. L., Schielen, P. C., Belmouden, I., Pennings, J. L. & Klipstein-Grobusch, K. Dried blood spot measurement of pregnancy-associated plasma protein A (PAPP-A) and free beta-subunit of human chorionic gonadotropin (beta-hCG) from a low-resource setting. Prenat. Diagn. 35, 592\u2013597 (2015).","journal-title":"Prenat. Diagn."},{"key":"580_CR24","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.fertnstert.2006.12.016","volume":"88","author":"A Edelman","year":"2007","unstructured":"Edelman, A., Stouffer, R., Zava, D. T. & Jensen, J. T. A comparison of blood spot vs. plasma analysis of gonadotropin and ovarian steroid hormone levels in reproductive-age women. Fertil. Steril. 88, 1404\u20131407 (2007).","journal-title":"Fertil. Steril."},{"key":"580_CR25","doi-asserted-by":"crossref","unstructured":"Gruner, N., Stambouli, O. & Ross, R. S. Dried blood spots\u2014preparing and processing for use in immunoassays and in molecular techniques. J. Vis. Exp. 52619 (2015).","DOI":"10.3791\/52619"},{"key":"580_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.7150\/ijbs.7268","volume":"9","author":"S Chaturvedi","year":"2013","unstructured":"Chaturvedi, S., Dell, E., Siegel, D., Brittingham, G. & Seetharam, S. Development of a rapid streptavidin capture-based assay for the tyrosine phosphorylated CSF-1R in peripheral blood mononuclear cells. Int. J. Biol. Sci. 9, 1099\u20131107 (2013).","journal-title":"Int. J. Biol. Sci."},{"key":"580_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.4155\/bio.14.297","volume":"7","author":"X Zhao","year":"2015","unstructured":"Zhao, X. et al. A clinical biomarker assay to quantitate thymic stromal lymphopoietin in human plasma at sub-pg\/ml level. Bioanalysis 7, 573\u2013582 (2015).","journal-title":"Bioanalysis"},{"key":"580_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2017.05.014","volume":"471","author":"A Leviton","year":"2017","unstructured":"Leviton, A. et al. Antecedents and early correlates of high and low concentrations of angiogenic proteins in extremely preterm newborns. Clin. Chim. Acta 471, 1\u20135 (2017).","journal-title":"Clin. Chim. Acta"},{"key":"580_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1373\/clinchem.2009.127514","volume":"56","author":"AA Ellington","year":"2010","unstructured":"Ellington, A. A., Kullo, I. J., Bailey, K. R. & Klee, G. G. Antibody-based protein multiplex platforms: technical and operational challenges. Clin. Chem. 56, 186\u2013193 (2010).","journal-title":"Clin. Chem."},{"key":"580_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2144\/000112332","volume":"42","author":"M Liew","year":"2007","unstructured":"Liew, M. et al. Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples. Biotechniques 42, 327\u2013328 (2007). 30-3.","journal-title":"Biotechniques"},{"key":"580_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/CVI.00211-07","volume":"15","author":"G Toedter","year":"2008","unstructured":"Toedter, G., Hayden, K., Wagner, C. & Brodmerkel, C. Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis. Clin. Vaccin. Immunol. 15, 42\u201348 (2008).","journal-title":"Clin. Vaccin. Immunol."},{"key":"580_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1172\/JCI110249","volume":"68","author":"WG McGregor","year":"1981","unstructured":"McGregor, W. G., Raymoure, W. J., Kuhn, R. W. & Jaffe, R. B. Fetal tissue can synthesize a placental hormone. Evidence for chorionic gonadotropin beta-subunit synthesis by human fetal kidney. J. Clin. Invest. 68, 306\u2013309 (1981).","journal-title":"J. Clin. Invest."},{"key":"580_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1210\/mend.15.1.0586","volume":"15","author":"ZM Lei","year":"2001","unstructured":"Lei, Z. M. et al. Targeted disruption of luteinizing hormone\/human chorionic gonadotropin receptor gene. Mol. Endocrinol. 15, 184\u2013200 (2001).","journal-title":"Mol. Endocrinol."},{"key":"580_CR34","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1542\/peds.2007-1327","volume":"121","author":"RF Greaves","year":"2008","unstructured":"Greaves, R. F., Hunt, R. W., Chiriano, A. S. & Zacharin, M. R. Luteinizing hormone and follicle-stimulating hormone levels in extreme prematurity: development of reference intervals. Pediatrics 121, e574\u2013e580 (2008).","journal-title":"Pediatrics"},{"key":"580_CR35","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.1007\/s00216-016-9818-z","volume":"408","author":"SV Egeland","year":"2016","unstructured":"Egeland, S. V., Reubsaet, L., Paus, E. & Halvorsen, T. G. Dual-immuno-MS technique for improved differentiation power in heterodimeric protein biomarker analysis: determination and differentiation of human chorionic gonadotropin variants in serum. Anal. Bioanal. Chem. 408, 7379\u20137391 (2016).","journal-title":"Anal. Bioanal. Chem."},{"key":"580_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/mas.21441","volume":"35","author":"M Wagner","year":"2016","unstructured":"Wagner, M., Tonoli, D., Varesio, E. & Hopfgartner, G. The use of mass spectrometry to analyze dried blood spots. Mass Spectrom. Rev. 35, 361\u2013438 (2016).","journal-title":"Mass Spectrom. Rev."},{"key":"580_CR37","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1021\/ac702628q","volume":"80","author":"RN Fichorova","year":"2008","unstructured":"Fichorova, R. N. et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal. Chem. 80, 4741\u20134751 (2008).","journal-title":"Anal. Chem."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0580-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:28:06Z","timestamp":1684618086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0580-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,19]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0580-8","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,19]]},"assertion":[{"value":"18 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.Z.M. is the Director and Principal Investigator at Zietchick Research Institute (ZRI), a private (for-profit) research institute, and has pending patent applications for the use of both gonadotropins and gonadotropin antagonists for the treatment of ocular disorders. A.M. is a salaried employee (no equity) at ZRI. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}